Австралия - английски - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - alogliptin benzoate, quantity: 17 mg - tablet, film coated - excipient ingredients: hyprolose; hypromellose; titanium dioxide; macrogol 8000; microcrystalline cellulose; mannitol; iron oxide yellow; croscarmellose sodium; magnesium stearate; shellac; ethanol absolute; iron oxide black; 1-butanol - vipidia is indicated to improve glycaemic control in adult patients (>=18 years old) with type 2 diabetes mellitus when diet and exercise do not provide adequate glycaemic control, as add on to metformin, a sulphonylurea, a thiazolidinedione, insulin (with or without metformin), or in combination with metformin and a thiazolidinedione when dual therapy does not provide adequate glycaemic control.

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - metformin hydrochloride; alogliptin benzoate - tablet - 1gram ; 12.5mg

Европейски съюз - английски - EMA (European Medicines Agency)

astrazeneca ab - metformin hydrochloride, saxagliptin, dapagliflozin - diabetes mellitus, type 2 - drugs used in diabetes - qtrilmet is indicated in adults aged 18 years and older with type 2 diabetes mellitus:to improve glycaemic control when metformin with or without sulphonylurea (su) and either saxagliptin or dapagliflozin does not provide adequate glycaemic control.when already being treated with metformin and saxagliptin and dapagliflozin.

Сингапур - английски - HSA (Health Sciences Authority)

takeda pharmaceuticals (asia pacific) pte. ltd. - alogliptin benzoate 17mg eqv. alogliptin; metformin hydrochloride - tablet, film coated - alogliptin benzoate 17mg eqv. alogliptin 12.5mg; metformin hydrochloride 500 mg

Европейски съюз - английски - EMA (European Medicines Agency)

takeda pharma a/s - alogliptin, pioglitazone - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - incresync is indicated as a second- or third-line treatment in adult patients aged 18 years and older with type-2 diabetes mellitus: , as an adjunct to diet and exercise to improve glycaemic control in adult patients (particularly overweight patients) inadequately controlled on pioglitazone alone, and for whom metformin is inappropriate due to contraindications or intolerance;, in combination with metformin (i.e. triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in adult patients (particularly overweight patients) inadequately controlled on their maximal tolerated dose of metformin and pioglitazone. , in addition, incresync can be used to replace separate tablets of alogliptin and pioglitazone in those adult patients aged 18 years and older with type-2 diabetes mellitus already being treated with this combination. after initiation of therapy with incresync, patients should be reviewed after three to six months to assess adequacy of response to treatment (e.g. reduction in hba1c). in patients who fail to show an adequate response, incresync should be discontinued. in light of potential risks with prolonged pioglitazone therapy, prescribers should confirm at subsequent routine reviews that the benefit of incresync is maintained (see section 4.4).,

Сингапур - английски - HSA (Health Sciences Authority)

takeda pharmaceuticals (asia pacific) pte. ltd. - alogliptin benzoate 17mg eqv alogliptin - tablet, film coated - alogliptin benzoate 17mg eqv alogliptin 12.5mg

Сингапур - английски - HSA (Health Sciences Authority)

takeda pharmaceuticals (asia pacific) pte. ltd. - alogliptin benzoate 34mg eqv alogliptin - tablet, film coated - alogliptin benzoate 34mg eqv alogliptin 25mg

Йордания - английски - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

الشركة العربية لصناعة الادوية المساهمة الخاصة - the arab pharmaceutical manufacturing psc - alogliptin as benzoate 12.5 mg - as benzoate 12.5 mg

Йордания - английски - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

الشركة العربية لصناعة الادوية المساهمة الخاصة - the arab pharmaceutical manufacturing psc - alogliptin as benzoate 25 mg - as benzoate 25 mg

Сингапур - английски - HSA (Health Sciences Authority)

takeda pharmaceuticals (asia pacific) pte. ltd. - alogliptin benzoate eqv. alogliptin; metformin hydrochloride - tablet, film coated - alogliptin benzoate eqv. alogliptin 12.5mg; metformin hydrochloride 1000 mg